Every patient is unique. As the US market leader in lipid injectable emulsions* (ILEs), Fresenius Kabi offers more choices to nourish critically or chronically ill patients of any ageāfrom hospital to home. With a full portfolio of ILEs, clinicians have access to more options for more patients.